Good Medicine Podcast

In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss look ahead to what 2026 could bring for medicine, public health, and drug development.They discuss early data suggesting major reductions in tuberculosis progression, how inflammation may reshape the way we treat cardiovascular disease, and why AI guided precision clinical trials are likely to become the norm. These changes could dramatically reduce cost, speed up development timelines, and improve success rates across medicine.This conversation is about where the field is headed next and why the coming years may look very different from the last decade.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Ryan Morley from Springtide Ventures to talk about early stage investing, entrepreneurship, and what it takes to build companies that truly improve human health.Ryan explains how Springtide focuses on partnering with early stage companies in health and life science technology, working closely with founders as they build and scale. Their approach is not just about capital, but about long term collaboration and helping companies navigate the complex healthcare ecosystem.The conversation also dives into purpose driven entrepreneurship. Ryan shares why so many founders he works with are motivated by deeply personal experiences and how that purpose shapes stronger companies. They close by discussing why understanding the end customer and aiming to elevate human health, not just incrementally improve healthcare, is critical for lasting impact.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

As 2025 comes to a close, Dr. David Bearss looks back on some of the most impactful conversations from the Good Medicine Podcast this year.This special recap episode highlights key moments from episodes on reverse brain aging, AI and innovation, live conversations at BYU, the science of exercise, precision medicine and cancer innovation, mental health, the human side of science, and reimagining healthcare and education.From cutting edge research to deeply human stories, these conversations reflect what Good Medicine is all about: thoughtful science, honest discussion, and a focus on improving health for individuals and communities.If you are new to the podcast, this is a great place to start. If you have been listening all year, this episode brings together the moments that defined 2025.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Jeremiah Bearss for a careful and educational discussion on vaccines, how they work, and how scientific evidence should be evaluated.They walk through the history of vaccines, how immune protection is created, and how vaccines have shaped public health over time. The conversation also addresses COVID-19, common concerns around vaccine safety, and the importance of properly interpreting data when looking at autism prevalence.Rather than relying on headlines or assumptions, this episode focuses on how science actually works, what the evidence shows, and why critical thinking matters when discussing complex health topics.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss hosts a special panel recorded at the BioUtah Life Science Summit. Joining him are Dr. Mark Ott, Dean of the BYU School of Medicine, and Dr. Bob Carter, physician executive at University of Utah Health.Together, they discuss some of the biggest challenges and opportunities facing healthcare in Utah. The conversation covers statewide genomics efforts, the growing strain on hospital capacity, the rise of at home care models, and what the next generation needs to understand about the future of biotechnology and medicine.This episode offers a direct look into the issues that will shape healthcare over the next decade and how Utah is preparing for the coming wave of aging citizens and increasing medical need.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, we are sharing a prerecorded panel hosted by Dr. David Bearss at the BioUtah Life Science Summit. The panel brings together leaders from across the industry, including Hariprasad Vankalapati of Biolexis, Alison O’Mahony of Seek Labs, and Ian Quigley of Leash Bio.Together, they discuss how artificial intelligence is beginning to reshape drug discovery, diagnostics, and the way companies make decisions. The conversation highlights how AI helps teams understand both positive and negative data, identify emerging threats, and improve the success rate of bringing new drugs to market. This panel offers a grounded look at how AI is being used in real life science organizations today and what the future may hold.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss speaks with Dr. Karson Kump of Aditum Bio, an organization focused on advancing treatments for unmet medical needs by guiding programs through development with a disciplined, data-driven approach.Dave opens the discussion by explaining how business development in life sciences is really about resource allocation. Scientists often follow what interests them, but companies must stay focused on what patients actually need and where the biggest gaps in medicine still exist.Karson shares how spending enough time in science humbles you. He explains that good decisions come from yielding to the science and letting objective data lead the way. At the same time, choosing to take a program outside your own company and into the world of partnerships can feel risky, even though it may be the best path forward.The conversation ends with Dave reflecting on ego, humility and delegation. In a field filled with smart, driven people, he has learned that real success comes from knowing when to step back and let someone who is better at a specific task take the lead.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss explore what fat is actually communicating to your brain and why the body often fights against weight loss.Jeremiah explains how the body is wired to hold onto fat as a survival mechanism. Fat storage has always been the backup plan for famine, injury, and cold, which means the body’s default mode is to protect those reserves in case something goes wrong.Dave discusses how inflammation influences this process. When the body is inflamed, fat can send signals to the brain that increase appetite and encourage the body to store even more fat. Reducing inflammation can help reverse that signal and make it easier to lose weight and keep it off.They also talk about the many different GLP-1 targets currently being explored and why inflammation may be the reason these drugs work for so many people. Jeremiah explains how the next phase of drug development and health innovation will likely focus on shifting the course of the obesity crisis.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Dr. Christin Glorioso of NeuroAge to explore new ideas in brain health and aging.Dr. Glorioso explains how NeuroAge’s comprehensive test measures your brain’s “age” and provides personalized recommendations to help you work toward reversing brain aging. She also talks about how aging itself is not a disease, but how aging increases the risk for many diseases such as Alzheimer’s, and why understanding brain age matters for long-term health.She also shares her interest in GLP-1 drugs and how she uses microdosing as part of her personal brain-health approach.This episode blends science, innovation, and practical strategies for anyone interested in staying mentally sharp as they age.Learn more about NeuroAge at https://www.neuroagetx.com/ You can test your reaction time for free and receive your first personalized recommendations to slow down your brain aging at https://app.neuroagetx.com/You can find Dr. Glorioso at:https://www.linkedin.com/in/christin-glorioso-md-phd-39627719/@DrGlorioso https://www.instagram.com/drglorioso/Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠

This week on the Good Medicine Podcast, Dr. David Bearss sits down with Zeke Misner of Medix Life Sciences to talk about improving access to care, speeding up innovation, and using AI responsibly in the life sciences industry.Dave opens the conversation by emphasizing that where you live or your ZIP code should not determine your health outcome. Zeke shares how technologies like artificial intelligence and data-driven processes are helping companies like Medix accelerate progress while maintaining strong ethical standards.Whether you’re interested in healthcare access, life sciences operations, or how AI is shaping the future of medicine, this episode offers both practical insights and big-picture perspective.Thank you to our sponsorsBioHive: https://www.biohive.comGalvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine PodcastInsta: ⁠https://www.instagram.com/good.medicine.podcast/⁠ X: ⁠https://x.com/GoodMedicinePod⁠ TikTok: ⁠https://www.tiktok.com/@good.medicine.podcast⁠ LinkedIn: ⁠https://www.linkedin.com/company/goodmedicinepodcast/⁠